Evidence map›Paper›PMID 37039685›Full record

ArticleRadiology2023

Quantitative CT Evaluation of Emphysema Progression over 10 Years in the COPDGene Study.

David Baraghoshi, Matthew Strand, Stephen M Humphries, Raúl San José Estépar, Gonzalo Vegas Sanchez-Ferrero, Jean-Paul Charbonnier, Rudolfs Latisenko, Edwin K Silverman, James D Crapo, David A Lynch

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Opportunistic Screening on Chest CT, From theAJR. American journal of roentgenology · 2026
    Review
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Post-COPD: Can Emphysema Be Repaired?American journal of respiratory and critical care medicine · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Is Disease Stability an Attainable Chronic Obstructive Pulmonary Disease Treatment Goal?American journal of respiratory and critical care medicine · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

David BaraghoshiFrom the Division of Biostatistics, Environment and Health (D.B., M.S.), Department of Radiology (S.M.H., D.A.L.), and Division of Pulmonary and Critical Care Medicine, Department of Medicine (J.D.C.), National Jewish Health, 1400 Jackson St, Denver, CO 80206; Applied Chest Imaging Laboratory (R.S.J.E., G.V.S.F.), Department of Radiology (R.S.J.E., G.V.S.F.), Channing Division of Network Medicine (E.K.S.), and Division of Pulmonary and Critical Care Medicine, Department of Medicine (E.K.S.), Brigham and Women's Hospital, Boston, Mass; and Thirona, Nijmegen, the Netherlands (J.P.C., R.L.).ORCID 0000-0002-9485-9267
Matthew StrandFrom the Division of Biostatistics, Environment and Health (D.B., M.S.), Department of Radiology (S.M.H., D.A.L.), and Division of Pulmonary and Critical Care Medicine, Department of Medicine (J.D.C.), National Jewish Health, 1400 Jackson St, Denver, CO 80206; Applied Chest Imaging Laboratory (R.S.J.E., G.V.S.F.), Department of Radiology (R.S.J.E., G.V.S.F.), Channing Division of Network Medicine (E.K.S.), and Division of Pulmonary and Critical Care Medicine, Department of Medicine (E.K.S.), Brigham and Women's Hospital, Boston, Mass; and Thirona, Nijmegen, the Netherlands (J.P.C., R.L.).ORCID 0000-0002-9083-5989
Stephen M HumphriesFrom the Division of Biostatistics, Environment and Health (D.B., M.S.), Department of Radiology (S.M.H., D.A.L.), and Division of Pulmonary and Critical Care Medicine, Department of Medicine (J.D.C.), National Jewish Health, 1400 Jackson St, Denver, CO 80206; Applied Chest Imaging Laboratory (R.S.J.E., G.V.S.F.), Department of Radiology (R.S.J.E., G.V.S.F.), Channing Division of Network Medicine (E.K.S.), and Division of Pulmonary and Critical Care Medicine, Department of Medicine (E.K.S.), Brigham and Women's Hospital, Boston, Mass; and Thirona, Nijmegen, the Netherlands (J.P.C., R.L.).ORCID 0000-0002-5113-4530
Raúl San José EstéparFrom the Division of Biostatistics, Environment and Health (D.B., M.S.), Department of Radiology (S.M.H., D.A.L.), and Division of Pulmonary and Critical Care Medicine, Department of Medicine (J.D.C.), National Jewish Health, 1400 Jackson St, Denver, CO 80206; Applied Chest Imaging Laboratory (R.S.J.E., G.V.S.F.), Department of Radiology (R.S.J.E., G.V.S.F.), Channing Division of Network Medicine (E.K.S.), and Division of Pulmonary and Critical Care Medicine, Department of Medicine (E.K.S.), Brigham and Women's Hospital, Boston, Mass; and Thirona, Nijmegen, the Netherlands (J.P.C., R.L.).ORCID 0000-0002-3677-1996
Gonzalo Vegas Sanchez-FerreroFrom the Division of Biostatistics, Environment and Health (D.B., M.S.), Department of Radiology (S.M.H., D.A.L.), and Division of Pulmonary and Critical Care Medicine, Department of Medicine (J.D.C.), National Jewish Health, 1400 Jackson St, Denver, CO 80206; Applied Chest Imaging Laboratory (R.S.J.E., G.V.S.F.), Department of Radiology (R.S.J.E., G.V.S.F.), Channing Division of Network Medicine (E.K.S.), and Division of Pulmonary and Critical Care Medicine, Department of Medicine (E.K.S.), Brigham and Women's Hospital, Boston, Mass; and Thirona, Nijmegen, the Netherlands (J.P.C., R.L.).ORCID 0000-0002-3803-4324
Jean-Paul CharbonnierFrom the Division of Biostatistics, Environment and Health (D.B., M.S.), Department of Radiology (S.M.H., D.A.L.), and Division of Pulmonary and Critical Care Medicine, Department of Medicine (J.D.C.), National Jewish Health, 1400 Jackson St, Denver, CO 80206; Applied Chest Imaging Laboratory (R.S.J.E., G.V.S.F.), Department of Radiology (R.S.J.E., G.V.S.F.), Channing Division of Network Medicine (E.K.S.), and Division of Pulmonary and Critical Care Medicine, Department of Medicine (E.K.S.), Brigham and Women's Hospital, Boston, Mass; and Thirona, Nijmegen, the Netherlands (J.P.C., R.L.).
Rudolfs LatisenkoFrom the Division of Biostatistics, Environment and Health (D.B., M.S.), Department of Radiology (S.M.H., D.A.L.), and Division of Pulmonary and Critical Care Medicine, Department of Medicine (J.D.C.), National Jewish Health, 1400 Jackson St, Denver, CO 80206; Applied Chest Imaging Laboratory (R.S.J.E., G.V.S.F.), Department of Radiology (R.S.J.E., G.V.S.F.), Channing Division of Network Medicine (E.K.S.), and Division of Pulmonary and Critical Care Medicine, Department of Medicine (E.K.S.), Brigham and Women's Hospital, Boston, Mass; and Thirona, Nijmegen, the Netherlands (J.P.C., R.L.).ORCID 0000-0002-0184-2838
Edwin K SilvermanFrom the Division of Biostatistics, Environment and Health (D.B., M.S.), Department of Radiology (S.M.H., D.A.L.), and Division of Pulmonary and Critical Care Medicine, Department of Medicine (J.D.C.), National Jewish Health, 1400 Jackson St, Denver, CO 80206; Applied Chest Imaging Laboratory (R.S.J.E., G.V.S.F.), Department of Radiology (R.S.J.E., G.V.S.F.), Channing Division of Network Medicine (E.K.S.), and Division of Pulmonary and Critical Care Medicine, Department of Medicine (E.K.S.), Brigham and Women's Hospital, Boston, Mass; and Thirona, Nijmegen, the Netherlands (J.P.C., R.L.).ORCID 0000-0002-3641-3822
James D CrapoFrom the Division of Biostatistics, Environment and Health (D.B., M.S.), Department of Radiology (S.M.H., D.A.L.), and Division of Pulmonary and Critical Care Medicine, Department of Medicine (J.D.C.), National Jewish Health, 1400 Jackson St, Denver, CO 80206; Applied Chest Imaging Laboratory (R.S.J.E., G.V.S.F.), Department of Radiology (R.S.J.E., G.V.S.F.), Channing Division of Network Medicine (E.K.S.), and Division of Pulmonary and Critical Care Medicine, Department of Medicine (E.K.S.), Brigham and Women's Hospital, Boston, Mass; and Thirona, Nijmegen, the Netherlands (J.P.C., R.L.).ORCID 0000-0002-1262-5230
David A LynchFrom the Division of Biostatistics, Environment and Health (D.B., M.S.), Department of Radiology (S.M.H., D.A.L.), and Division of Pulmonary and Critical Care Medicine, Department of Medicine (J.D.C.), National Jewish Health, 1400 Jackson St, Denver, CO 80206; Applied Chest Imaging Laboratory (R.S.J.E., G.V.S.F.), Department of Radiology (R.S.J.E., G.V.S.F.), Channing Division of Network Medicine (E.K.S.), and Division of Pulmonary and Critical Care Medicine, Department of Medicine (E.K.S.), Brigham and Women's Hospital, Boston, Mass; and Thirona, Nijmegen, the Netherlands (J.P.C., R.L.).ORCID 0000-0002-6329-2325
National Jewish Health · USBrigham and Women's Hospital · US

Funding

Genetic Epidemiology of COPDU01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2007 to 2021
$56.9M
Genetic Epidemiology of COPDU01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2021
$20.7M
(2 of 2) Genetic Epidemiology of COPDR01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2012 to 2016
$18.9M
Statistical Standardization of CT for the Analysis of Parenchymal Injury Progression in SmokersK25HL143278 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI VEGAS SANCHEZ-FERRERO, GONZALO · 2019 to 2023
$935k
Robust Detection of Early Small Airway DiseaseR21HL156229 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI VEGAS SANCHEZ-FERRERO, GONZALO · 2021 to 2022
$269k
NHLBI NIH HHS K25 HL143278NHLBI NIH HHS R01 HL089856NHLBI NIH HHS R21 HL156229NHLBI NIH HHS U01 HL089856NHLBI NIH HHS U01 HL089897
6 · The paper itself

Abstract

Background Long-term studies of chronic obstructive pulmonary disease (COPD) can evaluate emphysema progression. Adjustment for differences in equipment and scanning protocols of individual CT examinations have not been studied extensively. Purpose To evaluate emphysema progression in current and former smokers in the COPDGene cohort over three imaging points obtained at 5-year intervals accounting for individual CT parameters. Materials and Methods Current and former cigarette smokers enrolled between 2008 and 2011 from the COPDGene study were prospectively followed for 10 years between 2008 and 2020. Extent of emphysema as adjusted lung density (ALD) from quantitative CT was measured at baseline and at 5- and 10-year follow-up. Linear mixed models adjusted for CT technical characteristics were constructed to evaluate emphysema progression. Mean annual changes in ALD over consecutive 5-year study periods were estimated by smoking status and baseline emphysema. Results Of 8431 participants at baseline (mean age, 60 years ± 9 [SD]; 3905 female participants), 4913 were at 5-year follow-up and 1544 participants were at 10-year follow-up. There were 4134 (49%) participants who were current smokers, and 4449 (53%) participants had more than trace emphysema at baseline. Current smokers with more than trace emphysema showed the largest decline in ALD, with mean annual decreases of 1.4 g/L (95% CI: 1.2, 1.5) in the first 5 years and 0.9 g/L (95% CI: 0.7, 1.2) in the second 5 years. Accounting for CT noise, field of view, and scanner model improved model fit for estimation of emphysema progression (

Indexed as

EmphysemaPulmonary Disease, Chronic ObstructivePulmonary EmphysemaDisease ProgressionFemaleHumansLongitudinal StudiesLungMiddle AgedTomography, X-Ray Computed

Identifiers

PMID37039685
PMCPMC10286952
OpenAlexW4364352654

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.